Assessment of Cimetropium Bromide Use for the Detection of Gastric Neoplasms During Esophagogastroduodenoscopy
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.3827
Abstract: Key Points Question Is the use of cimetropium bromide, an antispasmodic agent, associated with higher rates of detection of gastric neoplasms during esophagogastroduodenoscopy (EGD) screening? Findings In this cohort study of 67 683 participants who received… read more here.
Keywords: detection gastric; gastric neoplasms; cimetropium bromide; use ... See more keywords